Monoclonal antibodies (mAbs) represent a major class of therapeutic biomolecules being developed by the biopharmaceutical industry, their popularity largely being a result of their high specificity towards targets. Therapeutic mAbs are being developed for various diseases, with a strong focus on cancer and immunological disorders.[1] All antibody drugs currently approved for clinical use are based on the immunoglobulin G (IgG) class; these molecules are composed of two heavy chains and two light chains, connected by disulfide bonds, and with a molecular weight of approximately 150 kDa. Antibody-based biopharmaceuticals can be complex and heterogeneous molecules, and a range of analytical tools are necessary to characterize them fully. © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
CITATION STYLE
Rosati, S., Rose, R. J., Thompson, N. J., Van Duijn, E., Damoc, E., Denisov, E., … Heck, A. J. R. (2012). Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. Angewandte Chemie - International Edition, 51(52), 12992–12996. https://doi.org/10.1002/anie.201206745
Mendeley helps you to discover research relevant for your work.